GO Term | Evidence Code | PMID |
---|---|---|
mismatch repair | ||
negative regulation of necroptotic process | ||
base-excision repair | ||
DNA repair | ||
depurination |
GO Term | Evidence Code | PMID |
---|---|---|
nucleus | ||
mitochondrion | ||
nucleoplasm |
GO Term | Evidence Code | PMID |
---|---|---|
DNA N-glycosylase activity | ||
MutLbeta complex binding | ||
adenine/guanine mispair binding | ||
4 iron, 4 sulfur cluster binding | ||
MutSalpha complex binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:7212 | meningothelial meningioma | |
DOID:7213 | transitional meningioma | |
DOID:77 | gastrointestinal system disease | |
DOID:7843 | female breast carcinoma | |
DOID:8057 | olfactory groove meningioma | |
DOID:8398 | osteoarthritis | |
DOID:848 | arthritis | |
DOID:8543 | Hodgkin's lymphoma, lymphocytic-histiocytic predominance | |
DOID:8567 | Hodgkin's lymphoma | |
DOID:8577 | ulcerative colitis |
HPO ID | HPO Term |
---|---|
HP:0002027 | Abdominal pain |
HP:0002076 | Migraine |
HP:0002167 | Abnormality of speech or vocalization |
HP:0002239 | Gastrointestinal hemorrhage |
HP:0002354 | Memory impairment |
HP:0002376 | Developmental regression |
HP:0002516 | Increased intracranial pressure |
HP:0002671 | Basal cell carcinoma |
HP:0002893 | Pituitary adenoma |
HP:0002894 | Neoplasm of the pancreas |
Disease ID | Disease Name |
---|---|
OMIM:613659 |
|
ORPHA:440437 |
|
ORPHA:247798 |
|
OMIM:608456 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
101613498 | JACJA22577 | ||
118318786 | SCOMX04239 | ||
102431707 | MYOLU11040 | ||
117026566 | RHIFE02956 | ||
100226093 | TAEGU29077 | ||
104662138 | RHIRO22742 | ||
114599092 | PODMU05598 | ||
109532070 | HIPCM01765 | ||
115381842 | SALFA44208 | ||
105814086 | PROCO20968 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024